A Randomized Controlled Trial of Palifermin (Recombinant Human Keratinocyte Growth Factor) for the Treatment of Inadequate CD4+ T-Lymphocyte Recovery in Patients with HIV-1 Infection on Antiretroviral Therapy-Reference-Cited by-同舟云学术

A Randomized Controlled Trial of Palifermin (Recombinant Human Keratinocyte Growth Factor) for the Treatment of Inadequate CD4+ T-Lymphocyte Recovery in Patients with HIV-1 Infection on Antiretroviral Therapy

Published:2014-08-01 Issue:4 Volume:66 Page:399-406
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Jacobson Jeffrey M.,Wang Hongying,Bordi Rebeka,Zheng Lu,Gross Barry H.,Landay Alan L.,Spritzler John,Routy Jean-Pierre,Benson Constance,Aberg Judith,Tebas Pablo,Haas David W.,Tiu Jennifer,Coughlin Kristine,Purdue Lynette,Sekaly Rafick-Pierre

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference33 articles.

1. . Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy.;Grabar;Ann Intern Med,2000

2. . Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen.;Piketty;J Infect Dis,2001

3. . Long-term outcomes among antiretroviral-naive human immunodeficiency virus-infected patients with small increases in CD4 cell counts after successful virologic suppression.;Dronda;Clin Infect Dis,2002

4. . The prognostic importance of changes in CD4 cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy.;Anastos;Ann Intern Med,2004

5. . Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies.;Chene;Lancet,2003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. (5R)-5-hydroxytriptolide for HIV immunological non-responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study;The Lancet Regional Health - Western Pacific;2023-05

2. Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions;Frontiers in Pediatrics;2022-01-11

3. Thymic Function and T-Cell Receptor Repertoire Diversity: Implications for Patient Response to Checkpoint Blockade Immunotherapy;Frontiers in Immunology;2021-11-24

4. End-Stage Renal Disease-Related Accelerated Immune Senescence: Is Rejuvenation of the Immune System a Therapeutic Goal?;Frontiers in Medicine;2021-09-03

5. Recapitulation of Thymic Function by Tissue Engineering Strategies;Advanced Healthcare Materials;2021-07